This inventor holds 1 USPTO granted patent. Top assignee: Bio Science International, Inc.. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: John-Jo McFadden: Innovator in Mycobacterial Diagnostics
Introduction: John-Jo McFadden is a distinguished inventor based in London, GB, known for his significant contribution to the field of diagnostics for mycobacteria. With one patent to his name, he has made strides in advancing public health, medical, and veterinary sciences through innovative DNA technology.
Latest Patents: John-Jo McFadden holds a patent titled "Diagnostics for Mycobacteria in Public Health, Medical, and Veterinary." This invention focuses on a family of DNA insertion sequences (ISMY) derived from mycobacteria and other DNA probes. These probes serve as essential tools in assay methods for identifying mycobacteria and distinguishing between closely related mycobacterial strains and species. Notably, his work allows for the differentiation of pathogenic M. paratuberculosis from M. avium, which is crucial for diagnosing Crohn's disease in humans and Johne's disease in animals. Furthermore, the patent also covers the use of ISMY along with the proteins and peptides encoded by ISMY in developing vaccines, pharmaceutical preparations, and diagnostic test kits.
Career Highlights: John-Jo McFadden is affiliated with Bio Science International, Inc., where he collaborates with a team of specialists dedicated to enhancing medical diagnostics. His career is marked by a commitment to merging scientific research with practical applications that address pressing health issues.
Collaborations: Among his notable collaborations is his partnership with John Hermon-Taylor, a fellow expert in the field. Together, they have worked on projects that explore the implications of mycobacterial diagnostics and contribute to the understanding of related diseases.
Conclusion: John-Jo McFadden's innovative work in the realm of mycobacterial diagnostics underscores the importance of research and development in combating infectious diseases. His contributions have significant implications for public health, reflecting a dedication to improving diagnostic methods and enhancing overall healthcare outcomes.